Trial
NCT05687721
Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
VA Office of Research and Development
Collaborators
Bayer
Condition
Advanced Urothelial Carcinoma
Intervention
copanlisib
Why stopped
The study drug is not available.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-15